Prevention of antibiotic-associated metabolic syndrome in mice by intestinal alkaline phosphatase

Diabetes, Obesity & Metabolism
Konstantinos P EconomopoulosRichard A Hodin

Abstract

To examine whether co-administration of intestinal alkaline phosphatase (IAP) with antibiotics early in life may have a preventive role against metabolic syndrome (MetS) in mice. A total of 50 mice were allocated to four treatment groups after weaning. Mice were treated with azithromycin (AZT) ± IAP, or with no AZT ± IAP, for three intermittent 7-day cycles. After the last treatment course, the mice were administered a regular chow diet for 5 weeks and subsequently a high-fat diet for 5 weeks. Body weight, food intake, water intake, serum lipids, glucose levels and liver lipids were compared. 16S rRNA gene pyrosequencing was used to determine the differences in microbiome composition. Exposure to AZT early in life rendered mice susceptible to MetS in adulthood. Co-administration of IAP with AZT completely prevented this susceptibility by decreasing total body weight, serum lipids, glucose levels and liver lipids to the levels of control mice. These effects of IAP probably occur as a result of changes in the composition of specific bacterial taxa at the genus and species levels (e.g. members of Anaeroplasma and Parabacteroides). Co-administration of IAP with AZT early in life prevents mice from susceptibility to the later develo...Continue Reading

References

Dec 30, 1952·Annals of the New York Academy of Sciences·H J ROBINSON
Oct 2, 2003·JAMA : the Journal of the American Medical Association·Lisa SaimanUNKNOWN Macrolide Study Group
Oct 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Fredrik BäckhedJeffrey I Gordon
Dec 22, 2006·Nature·Ruth E LeyJeffrey I Gordon
Apr 7, 2007·Chest·Anita L KozyrskyjAllan B Becker
Mar 10, 2009·Journal of Pediatric Gastroenterology and Nutrition·Christoph ReinhardtFredrik Bäckhed
Nov 10, 2009·Nature Reviews. Microbiology·Martin J Blaser, Stanley Falkow
May 6, 2010·JAMA : the Journal of the American Medical Association·Lisa SaimanUNKNOWN AZ0004 Azithromycin Study Group
Sep 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Les Dethlefsen, David A Relman
Oct 19, 2010·Gut Microbes·Courtney J Robinson, Vincent B Young
Oct 29, 2010·Genome Biology·Simon Anders, Wolfgang Huber
Mar 10, 2011·International Journal of Obesity : Journal of the International Association for the Study of Obesity·T A AjslevT Jess
Nov 9, 2011·Pediatrics·Adam L HershSamir S Shah
Jun 12, 2012·Pediatric Pulmonology·Lisa SaimanUNKNOWN AZ0004 Macrolide Study Team
Jan 12, 2013·American Journal of Physiology. Gastrointestinal and Liver Physiology·Angela K MossRichard A Hodin
Feb 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Junhee SeokUNKNOWN Inflammation and Host Response to Injury, Large Scale Collaborative Research Program
Feb 26, 2013·Neonatology·Fanny B MorelCatherine Michel
Mar 5, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M MillionM Paul
Apr 10, 2013·Proceedings of the National Academy of Sciences of the United States of America·Kanakaraju KaliannanRichard A Hodin
May 9, 2013·Journal of Proteome Research·Aifric O'SullivanCarolyn M Slupsky
Nov 29, 2013·Toxicologic Pathology·Benoit Chassaing, Andrew T Gewirtz
Dec 18, 2013·Nature·Lawrence A DavidPeter J Turnbaugh
Apr 12, 2014·American Journal of Physiology. Gastrointestinal and Liver Physiology·Madhu S MaloRichard A Hodin
Sep 10, 2014·Annals of Surgery·Sulaiman R HamarnehRichard A Hodin

❮ Previous
Next ❯

Citations

Nov 22, 2019·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Philip PlaekeBenedicte Y De Winter
Mar 21, 2017·Mediators of Inflammation·Jan BilskiTomasz Brzozowski
Dec 7, 2018·Disease Models & Mechanisms·Matthew T PereiraLaura Palanker Musselman
Oct 3, 2020·JCI Insight·Fatemeh AdiliaghdamRichard A Hodin
Mar 7, 2021·Microorganisms·Alyssa T Wilkins, Raylene A Reimer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.